Sitemap

Resources

• The Passionate Problem Solver
• Case Study – Secondary Sourcing Strategies to Ensure Supply Chain Security
• Case Study – Solubility Enhancement was Mission Critical for Nasal Epilepsy Treatment
• Meet the Machine: The Bausch 515 Aseptic Filling & Closing Machine
• Ophthalmic CDMO Services and Excipients Brochure
• What to Expect From Your Nanomilling Partner or Company
• Key Considerations for Ocular Drug Development & Solubility Enhancement Techniques
• How to Enhance the Solubility of Ocular Drug Products
• Case Study – Solving Solubility Challenges for a Novel Oncology Drug
• Designing Drug/Device Combination Products Quickly & Efficiently with Pathway™ TPU
• Clinical to Commercial Manufacturing: Selecting the Right CDMO for Your Sterile Drug Product
• How to Select the Right CDMO for Your Sterile Drug Product
• Solving Bioavailability Challenges Using A Drug Product’s Target Product Profile (TPP)
• Bridging Clinical and Commercial Drug Product Manufacturing – Outsourcing Advice from a CDMO
• Parenteral Drug Delivery Trends
• Ocular Implants for Drug Delivery: Improving Patient Outcomes
• Improving Bioavailability & Solubility: Each Molecule Is Unique
• Solubility and Bioavailability Enhancement Techniques
• Nasal Drug Formulation: A Guide to Successful Drug Product Development
• A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges
• 2021 Pharma Trends Shaping the CDMO Industry Outlook – with Barbara Morgan
• Long-Acting Drug Delivery: Injections, Implants, and Combination Products
• Phase Appropriate Filter Validation for Sterile Drug Product Manufacturing
• Filter Validation: Key Elements for Sterile Drug Product Manufacturing
• How Aseptic Nanomilling Can Provide a Solution for Today’s Insoluble Compounds Including HPCs
• A Guide to Solubility Improvement and Bioavailability Enhancement Techniques
• Excipient Selection and Supply for Complex Drug Products
• Molecule to Market Podcast: The Value of Diversity in Pharma
• Incorporation of Dexamethasone Into Silicone Drug-Device Combination Products
• A Pharmaceutical Guide to Cannabis – FAQs for Drug Product Development
• Combination Products for Medical Device Developers
• A Guide to Vaccine Development & Immunization
• Lyophilization of Complex Drug Products: Formulation Challenges and Scale-Up
• Manufacturing Sterile Products
• Improving Bioavailability & Solubility
• Women in Pharma: Reimagining the Glass Ceiling
• The Year That Was and the Year That Will Be
• Ophthalmic Drug Delivery for Retinal Disorders
• Hot Melt Extrusion for Oral Solid Dosage Forms
• The Guide to Analytical Method Development
• Targeted Therapeutics and Nanoparticles
• Optimizing Ophthalmic Drug Delivery for Therapeutic Effectiveness
• Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 2
• Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 1
• Nanomilling: Shaping the Solubility and Bioavailability of Today’s Therapeutics
• Overcoming the Challenges in Drug-Device Combination Product Formulation
• The Demands of the Perfect Dose
• Overcoming Challenges in Ophthalmic Drug Delivery including Bioavailability and Sterility
• Insoluble APIs Scaring You? Don’t Be Afraid of Nanotechnology!
• Implantable Systems and Microparticle Depots Webinar
• Aseptic Nanomilling Presentation
• Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
• Code of Federal Regulations Title 21 Part 11 Requirements
• In Vitro Dissolution Testing For Solid Oral Dosage Forms
• How Personalized Medicine is Evolving the CDMO Landscape
• Physical Stability of Disperse Systems
• Drug Substance Solid State Characterization
• Biopharmaceutical Classification System
• Solid Lipid Nanoparticles
• Glossary of Nanotech
• Quality by Design
• Process Analytical Technology
• Phase Behavior of Surface-Active Solutes
• Cubic Phase Particles
• Solid Solutions and Dispersions
• Overview of the Zeta Potential
• Nanotechnology – New Name – Old Science
• Solubility – Ideal Solubility & Solubility Models
• Sampling of Powders
• Potent Compound Handling Operations
• Hot Melt Extrusion
• Emulsion Stability and Testing
• Glossary of Polymer Terms
• Encapsulation
• Mechanical Dispersing of Insoluble APIs
• Dissolution Testing for OSD
• The Patent Process
• Dissolving Films
• Combination Devices
• Surfactants
• Development and Validation of In Vitro Release Testing for Semisolid Formulations
• Emulsions and Emulsifications
• Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
• Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
• Analytical Method Development and Validation
• Mass Spectrometry in Bioanalysis
• Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
• Particle Size Distribution and Its Measurement
• Lyophilization of Pharmaceuticals: An Overview
• Orphan Drug Product Development: Incentives and Outsourcing Considerations
• Understanding Analytical Method Validation with Laurie Goldman
• The FDA’s Recent Uptick in Ophthalmic NDA & BLA Approvals
• Overcoming Solubility Challenges: Techniques to Improve Dissolution Rate and Increase Bioavailability
• Highly Potent API (HPAPI) Handling: An Expert Interview with Judy Cohen
• Aseptic Manufacturing and Sterile Fill-Finish for Complex Drug Products
• 6 Takeaways from the FDA’s Complex Generic Drug Product Development Workshop
• Hot Melt Extrusion: Solubility Enhancement, Controlled Release, and More
• Why the FDA Loves Complex Generic Drug Products
• Nanomilling: A Key Option for Formulating Water-Insoluble APIs
• What are Complex Drug Products and Why Should You Care?